Table 7.
Sample description
| Characteristic | SNP (n = 8) | PLHIV (n = 8) | p-value |
|---|---|---|---|
| Age in years, mean (SD) | 28.84 (8.11) | 36.61 (9.44) | 0.10 |
| Female sex, n (%) | 6 (75) | 4 (50) | 0.30 |
| Height (m), mean (SD) | 1.59 (0.09) | 1.64 (0.08) | 0.20 |
| Weight (kg), mean (SD) | 49.51 (11.24) | 57.23 (9.99) | 0.17 |
| BMI (kg/m2), mean (SD) | 19.54 (3.03) | 21.19 (3.50) | 0.33 |
| Leg length (cm), mean (SD) | 84.72 (5.52) | 85.86 (4.40) | 0.65 |
| Most recent CD4+ T-cell count (cells/µL), mean (SD) | – | 558.25 (181.80) | – |
| Detectable viral load (> 50 cp/mL), n (%) | – | 6 (75) | – |
| Years since HIV diagnosis, n (%) | – | ||
| < 2 years | – | 4 (50) | – |
| 2–5 years | – | 2 (25) | – |
| 5–15 years | – | 1 (12.5) | – |
| > 15 years | – | 1 (12.5) | – |
| On ART, n (%) | – | 6 (75) | – |
| ART duration in weeks, median (IQR) | – | 71.50 (16.00–465.00) | – |
BMI body mass index, ART antiretroviral therapy, PLHIV people living with HIV-1 infection, SNP HIV-seronegative participants